GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf5
|
ENSRNOG00000008282 | E74-like factor 5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Elf5 | rn6_v1_chr3_+_93351619_93351619 | -0.13 | 1.6e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_61425746 | 36.31 |
ENSRNOT00000064113
|
RGD1305807
|
hypothetical LOC298077 |
chr8_-_114853103 | 35.60 |
ENSRNOT00000074595
|
Glyctk
|
glycerate kinase |
chr1_+_148240504 | 25.26 |
ENSRNOT00000085373
|
LOC100361547
|
Cytochrome P450, family 2, subfamily c, polypeptide 7-like |
chr1_-_219682287 | 25.01 |
ENSRNOT00000026092
|
Rhod
|
ras homolog family member D |
chr4_+_154215250 | 24.11 |
ENSRNOT00000072465
|
Mug2
|
murinoglobulin 2 |
chr17_+_22619891 | 21.55 |
ENSRNOT00000060403
|
Adtrp
|
androgen-dependent TFPI-regulating protein |
chr1_+_201620642 | 21.15 |
ENSRNOT00000093674
|
Dmbt1
|
deleted in malignant brain tumors 1 |
chr2_-_164684985 | 21.02 |
ENSRNOT00000057504
|
Rarres1
|
retinoic acid receptor responder 1 |
chr17_+_22620721 | 20.87 |
ENSRNOT00000019478
|
Adtrp
|
androgen-dependent TFPI-regulating protein |
chr1_-_258875572 | 19.67 |
ENSRNOT00000093005
|
Cyp2c13
|
cytochrome P450, family 2, subfamily c, polypeptide 13 |
chr13_+_89774764 | 19.33 |
ENSRNOT00000005619
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr13_-_55173692 | 19.01 |
ENSRNOT00000064785
ENSRNOT00000029878 ENSRNOT00000029865 ENSRNOT00000060292 ENSRNOT00000000814 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr15_-_29246222 | 18.52 |
ENSRNOT00000081806
|
AABR07017617.1
|
|
chr2_+_199796881 | 18.51 |
ENSRNOT00000024423
|
Fmo5
|
flavin containing monooxygenase 5 |
chr17_+_9736577 | 18.49 |
ENSRNOT00000066586
|
F12
|
coagulation factor XII |
chr1_-_48563776 | 18.40 |
ENSRNOT00000023368
|
Plg
|
plasminogen |
chr3_+_119015412 | 18.06 |
ENSRNOT00000013605
|
Slc27a2
|
solute carrier family 27 member 2 |
chr2_+_114423533 | 17.88 |
ENSRNOT00000091221
|
Slc2a2
|
solute carrier family 2 member 2 |
chr16_+_6970342 | 17.86 |
ENSRNOT00000061294
ENSRNOT00000048344 |
Itih4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr20_+_3990820 | 17.85 |
ENSRNOT00000000528
|
Psmb8
|
proteasome subunit beta 8 |
chr15_-_29443454 | 17.75 |
ENSRNOT00000082167
|
AABR07017635.2
|
|
chr8_+_119261747 | 17.48 |
ENSRNOT00000079648
|
AC132539.1
|
|
chr1_-_219311502 | 17.45 |
ENSRNOT00000085439
|
RGD1307603
|
similar to hypothetical protein MGC37914 |
chr14_+_44889287 | 17.37 |
ENSRNOT00000091312
ENSRNOT00000032273 |
Tmem156
|
transmembrane protein 156 |
chr5_+_154522119 | 17.33 |
ENSRNOT00000072618
|
E2f2
|
E2F transcription factor 2 |
chr1_+_201687758 | 17.30 |
ENSRNOT00000093308
|
Dmbt1
|
deleted in malignant brain tumors 1 |
chr20_-_14025067 | 17.25 |
ENSRNOT00000093430
ENSRNOT00000074533 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr7_-_142318620 | 17.23 |
ENSRNOT00000006351
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr8_-_71533069 | 17.20 |
ENSRNOT00000021863
|
Trip4
|
thyroid hormone receptor interactor 4 |
chr19_-_64303 | 17.05 |
ENSRNOT00000015451
|
Ces2a
|
carboxylesterase 2A |
chr4_-_34282351 | 16.89 |
ENSRNOT00000011123
|
Rpa3
|
replication protein A3 |
chr2_+_181987217 | 16.86 |
ENSRNOT00000034521
|
Fgg
|
fibrinogen gamma chain |
chr4_-_117568348 | 16.82 |
ENSRNOT00000071447
|
Nat8f2
|
N-acetyltransferase 8 (GCN5-related) family member 2 |
chr8_+_116857684 | 16.44 |
ENSRNOT00000026711
|
Mst1
|
macrophage stimulating 1 |
chr18_-_24823837 | 16.07 |
ENSRNOT00000021405
ENSRNOT00000090390 |
Myo7b
|
myosin VIIb |
chr9_+_81689802 | 15.69 |
ENSRNOT00000021432
|
Vil1
|
villin 1 |
chr20_+_5441876 | 15.65 |
ENSRNOT00000092476
|
Rps18
|
ribosomal protein S18 |
chr1_-_226657408 | 15.55 |
ENSRNOT00000028102
|
Tkfc
|
triokinase and FMN cyclase |
chr1_+_229030233 | 15.52 |
ENSRNOT00000084503
|
Glyatl1
|
glycine-N-acyltransferase-like 1 |
chr5_+_142845114 | 14.87 |
ENSRNOT00000039870
|
Yrdc
|
yrdC N(6)-threonylcarbamoyltransferase domain containing |
chr1_+_141986145 | 14.78 |
ENSRNOT00000030914
|
Sema4b
|
semaphorin 4B |
chr4_-_157263890 | 14.71 |
ENSRNOT00000065416
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr3_+_164665532 | 14.56 |
ENSRNOT00000014309
|
Ptpn1
|
protein tyrosine phosphatase, non-receptor type 1 |
chr4_+_22082194 | 14.36 |
ENSRNOT00000091799
|
Crot
|
carnitine O-octanoyltransferase |
chr10_-_94979259 | 14.34 |
ENSRNOT00000018394
|
Polg2
|
DNA polymerase gamma 2, accessory subunit |
chr20_+_28989491 | 14.06 |
ENSRNOT00000074524
|
Pla2g12b
|
phospholipase A2, group XIIB |
chr8_-_71533459 | 14.04 |
ENSRNOT00000085745
|
Trip4
|
thyroid hormone receptor interactor 4 |
chr5_-_160403373 | 13.88 |
ENSRNOT00000018393
|
Ctrc
|
chymotrypsin C |
chr1_+_83653234 | 13.78 |
ENSRNOT00000085008
ENSRNOT00000084230 ENSRNOT00000090071 |
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr14_+_10534423 | 13.71 |
ENSRNOT00000002983
|
Hpse
|
heparanase |
chr13_+_90759260 | 13.68 |
ENSRNOT00000010551
|
Pigm
|
phosphatidylinositol glycan anchor biosynthesis, class M |
chr15_+_60084918 | 13.64 |
ENSRNOT00000012632
|
Epsti1
|
epithelial stromal interaction 1 |
chr13_-_91427575 | 13.57 |
ENSRNOT00000012092
|
Apcs
|
amyloid P component, serum |
chr17_+_9736786 | 13.53 |
ENSRNOT00000081920
|
F12
|
coagulation factor XII |
chr15_+_30785248 | 13.49 |
ENSRNOT00000089085
|
AABR07017768.5
|
|
chr15_-_29761117 | 13.39 |
ENSRNOT00000075194
|
AABR07017658.2
|
|
chr15_-_30323833 | 13.34 |
ENSRNOT00000071631
|
AABR07017714.1
|
|
chr10_-_37209881 | 13.34 |
ENSRNOT00000090475
|
Sec24a
|
SEC24 homolog A, COPII coat complex component |
chr15_+_31097291 | 13.26 |
ENSRNOT00000075456
|
AABR07017789.1
|
|
chr14_+_88549947 | 13.17 |
ENSRNOT00000086177
|
Hnrnpc
|
heterogeneous nuclear ribonucleoprotein C |
chr15_+_32012543 | 13.11 |
ENSRNOT00000078174
|
AABR07017868.5
|
|
chr4_-_69268336 | 13.10 |
ENSRNOT00000018042
|
Prss3b
|
protease, serine, 3B |
chr7_+_143629455 | 13.09 |
ENSRNOT00000073951
|
Krt18
|
keratin 18 |
chr1_+_221448661 | 12.94 |
ENSRNOT00000072493
|
LOC100910252
|
sororin-like |
chr14_+_7073445 | 12.91 |
ENSRNOT00000003004
|
Hsd17b11
|
hydroxysteroid (17-beta) dehydrogenase 11 |
chr3_-_150603082 | 12.91 |
ENSRNOT00000024310
|
Ahcy
|
adenosylhomocysteinase |
chr19_+_46761570 | 12.81 |
ENSRNOT00000058779
|
Wwox
|
WW domain-containing oxidoreductase |
chr9_-_92435363 | 12.68 |
ENSRNOT00000093735
ENSRNOT00000022822 ENSRNOT00000093245 |
Trip12
|
thyroid hormone receptor interactor 12 |
chr4_+_157523320 | 12.32 |
ENSRNOT00000023192
|
Zfp384
|
zinc finger protein 384 |
chr10_+_83655460 | 12.21 |
ENSRNOT00000008011
|
Gngt2
|
G protein subunit gamma transducin 2 |
chr6_-_36940868 | 12.21 |
ENSRNOT00000006470
|
Gen1
|
GEN1 Holliday junction 5' flap endonuclease |
chr1_-_213907144 | 12.20 |
ENSRNOT00000054874
|
Sigirr
|
single Ig and TIR domain containing |
chr12_-_45182974 | 12.17 |
ENSRNOT00000001503
|
Taok3
|
TAO kinase 3 |
chr20_+_26755911 | 12.08 |
ENSRNOT00000083017
|
Herc4
|
HECT and RLD domain containing E3 ubiquitin protein ligase 4 |
chr1_+_248723397 | 12.04 |
ENSRNOT00000072188
|
LOC100911854
|
mannose-binding protein C-like |
chr17_-_79798435 | 11.92 |
ENSRNOT00000022986
|
Fam188a
|
family with sequence similarity 188, member A |
chr12_+_2180150 | 11.87 |
ENSRNOT00000001322
|
Stxbp2
|
syntaxin binding protein 2 |
chr1_+_264893162 | 11.77 |
ENSRNOT00000021714
|
Tlx1
|
T-cell leukemia, homeobox 1 |
chr2_+_244521699 | 11.67 |
ENSRNOT00000029382
|
Stpg2
|
sperm-tail PG-rich repeat containing 2 |
chr15_+_32324830 | 11.66 |
ENSRNOT00000071598
|
AABR07017895.1
|
|
chr1_+_282567674 | 11.59 |
ENSRNOT00000090543
|
Ces2i
|
carboxylesterase 2I |
chr4_-_70747226 | 11.54 |
ENSRNOT00000044960
|
LOC102554637
|
anionic trypsin-2-like |
chr19_+_487723 | 11.47 |
ENSRNOT00000061734
|
Ces2j
|
carboxylesterase 2J |
chr14_+_115166416 | 11.44 |
ENSRNOT00000088916
ENSRNOT00000078329 |
Psme4
|
proteasome activator subunit 4 |
chr3_-_152222647 | 11.30 |
ENSRNOT00000026820
|
Nfs1
|
NFS1 cysteine desulfurase |
chr1_-_146289465 | 11.02 |
ENSRNOT00000017362
|
Abhd17c
|
abhydrolase domain containing 17C |
chr5_+_25042710 | 10.96 |
ENSRNOT00000061385
|
RGD1559904
|
similar to mKIAA1429 protein |
chr3_-_151688149 | 10.93 |
ENSRNOT00000072945
|
Nfs1
|
NFS1 cysteine desulfurase |
chr4_+_157523110 | 10.92 |
ENSRNOT00000081640
|
Zfp384
|
zinc finger protein 384 |
chr1_+_100832324 | 10.90 |
ENSRNOT00000056364
|
Il4i1
|
interleukin 4 induced 1 |
chr1_+_282694906 | 10.89 |
ENSRNOT00000074303
|
Ces2c
|
carboxylesterase 2C |
chr15_-_29465807 | 10.82 |
ENSRNOT00000075046
|
AABR07017635.1
|
|
chr7_-_101140308 | 10.59 |
ENSRNOT00000006279
|
Fam84b
|
family with sequence similarity 84, member B |
chr9_-_9985358 | 10.59 |
ENSRNOT00000080856
|
Crb3
|
crumbs 3, cell polarity complex component |
chr6_-_143065639 | 10.54 |
ENSRNOT00000070923
|
AABR07065827.1
|
|
chr13_+_51958834 | 10.53 |
ENSRNOT00000007833
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr10_-_107114271 | 10.48 |
ENSRNOT00000004035
|
Dnah17
|
dynein, axonemal, heavy chain 17 |
chr19_-_21492468 | 10.45 |
ENSRNOT00000087660
ENSRNOT00000048345 ENSRNOT00000020770 |
Lonp2
|
lon peptidase 2, peroxisomal |
chr2_+_60131776 | 10.44 |
ENSRNOT00000080786
|
Prlr
|
prolactin receptor |
chr19_+_55094585 | 10.44 |
ENSRNOT00000068452
|
Zfpm1
|
zinc finger protein, multitype 1 |
chr9_-_26707571 | 10.43 |
ENSRNOT00000080948
|
AABR07067023.1
|
|
chr7_+_2458264 | 10.42 |
ENSRNOT00000003550
|
Naca
|
nascent polypeptide-associated complex alpha subunit |
chr4_-_133127175 | 10.41 |
ENSRNOT00000057758
|
Shq1
|
SHQ1, H/ACA ribonucleoprotein assembly factor |
chr15_+_31989041 | 10.39 |
ENSRNOT00000073686
|
AABR07017868.2
|
|
chr9_-_61528882 | 10.28 |
ENSRNOT00000015432
|
Ankrd44
|
ankyrin repeat domain 44 |
chr12_-_2826378 | 10.25 |
ENSRNOT00000061749
|
Clec4m
|
C-type lectin domain family 4 member M |
chrX_+_72684329 | 10.12 |
ENSRNOT00000057644
|
Dmrtc1c1
|
DMRT-like family C1c1 |
chr7_+_14486638 | 10.10 |
ENSRNOT00000007548
|
Cyp4f39
|
cytochrome P450, family 4, subfamily f, polypeptide 39 |
chr5_-_134348995 | 10.07 |
ENSRNOT00000015961
|
Faah
|
fatty acid amide hydrolase |
chr7_+_141053876 | 10.04 |
ENSRNOT00000084674
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr10_-_5344121 | 10.01 |
ENSRNOT00000003479
|
Nubp1
|
nucleotide binding protein 1 |
chr13_-_37287458 | 9.99 |
ENSRNOT00000003391
|
Insig2
|
insulin induced gene 2 |
chrX_-_79066932 | 9.99 |
ENSRNOT00000057460
|
RGD1561552
|
similar to WASP family 1 |
chr17_-_90755852 | 9.95 |
ENSRNOT00000003526
|
Ero1b
|
endoplasmic reticulum oxidoreductase 1 beta |
chr3_+_16610086 | 9.91 |
ENSRNOT00000046231
|
LOC100361009
|
rCG64257-like |
chr1_+_219403970 | 9.85 |
ENSRNOT00000029607
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C-associated protein |
chr20_+_5509059 | 9.85 |
ENSRNOT00000065349
|
Kifc1
|
kinesin family member C1 |
chr19_-_50220455 | 9.80 |
ENSRNOT00000079760
|
Sdr42e1
|
short chain dehydrogenase/reductase family 42E, member 1 |
chr3_-_48372583 | 9.79 |
ENSRNOT00000040482
ENSRNOT00000077788 ENSRNOT00000085426 |
Dpp4
|
dipeptidylpeptidase 4 |
chr1_+_219759183 | 9.77 |
ENSRNOT00000026316
|
Pc
|
pyruvate carboxylase |
chr1_+_220325352 | 9.61 |
ENSRNOT00000027258
|
LOC108348098
|
breast cancer metastasis-suppressor 1 homolog |
chr5_-_142845116 | 9.60 |
ENSRNOT00000065105
|
RGD1559909
|
RGD1559909 |
chr8_+_96551245 | 9.60 |
ENSRNOT00000039850
|
Bcl2a1
|
BCL2-related protein A1 |
chr10_+_61746082 | 9.59 |
ENSRNOT00000003992
|
Tsr1
|
TSR1, ribosome maturation factor |
chr1_+_199019289 | 9.58 |
ENSRNOT00000087142
|
Phkg2
|
phosphorylase kinase catalytic subunit gamma 2 |
chr3_+_19045214 | 9.57 |
ENSRNOT00000070878
|
AABR07051670.1
|
|
chr4_+_101645731 | 9.55 |
ENSRNOT00000087901
|
AABR07060953.1
|
|
chr9_-_42805673 | 9.50 |
ENSRNOT00000020558
|
Uggt1
|
UDP-glucose glycoprotein glucosyltransferase 1 |
chr13_-_90022269 | 9.50 |
ENSRNOT00000035498
|
Ly9
|
lymphocyte antigen 9 |
chr16_-_23991570 | 9.48 |
ENSRNOT00000044198
ENSRNOT00000018854 |
Nat2
Nat1
|
N-acetyltransferase 2 N-acetyltransferase 1 |
chr16_-_9430743 | 9.47 |
ENSRNOT00000043811
|
Wdfy4
|
WDFY family member 4 |
chr9_-_16581078 | 9.45 |
ENSRNOT00000022582
|
Pex6
|
peroxisomal biogenesis factor 6 |
chr1_-_251338358 | 9.41 |
ENSRNOT00000002054
|
Cyp2b15
|
cytochrome P450, family 2, subfamily b, polypeptide 15 |
chr5_-_58124681 | 9.40 |
ENSRNOT00000019795
|
Sigmar1
|
sigma non-opioid intracellular receptor 1 |
chr10_+_12046701 | 9.35 |
ENSRNOT00000011073
ENSRNOT00000084004 |
Mefv
|
MEFV, pyrin innate immunity regulator |
chr1_-_227932603 | 9.34 |
ENSRNOT00000033795
|
Ms4a6a
|
membrane spanning 4-domains A6A |
chr2_+_227455722 | 9.32 |
ENSRNOT00000064809
|
Sec24d
|
SEC24 homolog D, COPII coat complex component |
chr4_+_100209951 | 9.30 |
ENSRNOT00000015807
|
LOC691113
|
hypothetical protein LOC691113 |
chr1_+_260289589 | 9.29 |
ENSRNOT00000051058
|
Dntt
|
DNA nucleotidylexotransferase |
chr7_+_14865941 | 9.23 |
ENSRNOT00000066654
|
Cyp4f40
|
cytochrome P450, family 4, subfamily f, polypeptide 40 |
chr8_-_128665988 | 9.19 |
ENSRNOT00000050543
|
Csrnp1
|
cysteine and serine rich nuclear protein 1 |
chr17_-_9837293 | 9.15 |
ENSRNOT00000091320
ENSRNOT00000022134 |
Prelid1
|
PRELI domain containing 1 |
chr4_-_117584819 | 9.11 |
ENSRNOT00000090815
|
Nat8f1
|
N-acetyltransferase 8 (GCN5-related) family member 1 |
chr8_-_6076598 | 9.08 |
ENSRNOT00000090774
|
Birc3
|
baculoviral IAP repeat-containing 3 |
chr9_+_8052210 | 9.01 |
ENSRNOT00000073659
|
Adgre4
|
adhesion G protein-coupled receptor E4 |
chr6_+_12253788 | 9.00 |
ENSRNOT00000061675
|
Ppp1r21
|
protein phosphatase 1, regulatory subunit 21 |
chr10_+_3321476 | 8.99 |
ENSRNOT00000090166
|
Mpv17l
|
MPV17 mitochondrial inner membrane protein like |
chr9_-_54484533 | 8.99 |
ENSRNOT00000083514
|
Stat1
|
signal transducer and activator of transcription 1 |
chr6_+_91476698 | 8.98 |
ENSRNOT00000005608
|
Mgat2
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr1_+_199019517 | 8.97 |
ENSRNOT00000025419
|
Phkg2
|
phosphorylase kinase catalytic subunit gamma 2 |
chr4_+_163162211 | 8.94 |
ENSRNOT00000082537
|
Clec1b
|
C-type lectin domain family 1, member B |
chr4_+_112773938 | 8.93 |
ENSRNOT00000009321
|
Eva1a
|
eva-1 homolog A, regulator of programmed cell death |
chr1_-_48360131 | 8.92 |
ENSRNOT00000051927
ENSRNOT00000023116 |
Slc22a2
|
solute carrier family 22 member 2 |
chr8_-_37450340 | 8.90 |
ENSRNOT00000072224
|
LOC100912405
|
urinary protein 3-like |
chr11_+_70967439 | 8.81 |
ENSRNOT00000032518
|
Iqcg
|
IQ motif containing G |
chr10_+_109665682 | 8.81 |
ENSRNOT00000054963
|
Slc25a10
|
solute carrier family 25 member 10 |
chr18_-_31071371 | 8.77 |
ENSRNOT00000060432
|
Diaph1
|
diaphanous-related formin 1 |
chrX_+_15155230 | 8.76 |
ENSRNOT00000073289
ENSRNOT00000051439 |
Was
|
Wiskott-Aldrich syndrome |
chr13_-_50549981 | 8.76 |
ENSRNOT00000003918
ENSRNOT00000080486 |
Golt1a
|
golgi transport 1A |
chr8_-_49271834 | 8.69 |
ENSRNOT00000085022
|
Ube4a
|
ubiquitination factor E4A |
chr17_-_76410294 | 8.67 |
ENSRNOT00000023892
|
Nudt5
|
nudix hydrolase 5 |
chr3_+_175629374 | 8.65 |
ENSRNOT00000084027
|
Rps21
|
ribosomal protein S21 |
chr10_-_47546345 | 8.63 |
ENSRNOT00000077461
|
Aldh3a2
|
aldehyde dehydrogenase 3 family, member A2 |
chr10_-_57275708 | 8.63 |
ENSRNOT00000005370
|
Pfn1
|
profilin 1 |
chr9_+_43331155 | 8.55 |
ENSRNOT00000023036
|
Zap70
|
zeta chain of T cell receptor associated protein kinase 70 |
chr8_-_103608913 | 8.54 |
ENSRNOT00000013209
|
Pls1
|
plastin 1 |
chr5_+_137670295 | 8.54 |
ENSRNOT00000076672
|
Ebna1bp2
|
EBNA1 binding protein 2 |
chr1_-_98493978 | 8.52 |
ENSRNOT00000023942
|
Nkg7
|
natural killer cell granule protein 7 |
chr7_-_121783435 | 8.50 |
ENSRNOT00000034912
|
Enthd1
|
ENTH domain containing 1 |
chr1_-_198225580 | 8.50 |
ENSRNOT00000026909
|
Ppp4c
|
protein phosphatase 4, catalytic subunit |
chr3_-_114064389 | 8.44 |
ENSRNOT00000022875
|
Spg11
|
spastic paraplegia 11 (autosomal recessive) |
chr8_-_116872215 | 8.44 |
ENSRNOT00000045410
|
Apeh
|
acylaminoacyl-peptide hydrolase |
chr1_+_221424383 | 8.40 |
ENSRNOT00000028482
|
Znhit2
|
zinc finger, HIT-type containing 2 |
chr3_-_8659102 | 8.37 |
ENSRNOT00000050908
|
Zdhhc12
|
zinc finger, DHHC-type containing 12 |
chr10_+_12046541 | 8.36 |
ENSRNOT00000081191
|
Mefv
|
MEFV, pyrin innate immunity regulator |
chr20_+_3299730 | 8.32 |
ENSRNOT00000078538
|
Prr3
|
proline rich 3 |
chr1_+_170471238 | 8.31 |
ENSRNOT00000076961
ENSRNOT00000075597 ENSRNOT00000076631 ENSRNOT00000076783 |
Timm10b
Dnhd1
|
translocase of inner mitochondrial membrane 10B dynein heavy chain domain 1 |
chr6_-_139747737 | 8.27 |
ENSRNOT00000090626
|
AABR07065705.3
|
|
chrX_-_106576314 | 8.25 |
ENSRNOT00000037823
|
Nxf3
|
nuclear RNA export factor 3 |
chr9_-_10897240 | 8.24 |
ENSRNOT00000074502
|
Tnfaip8l1
|
TNF alpha induced protein 8 like 1 |
chr1_+_81763614 | 8.24 |
ENSRNOT00000027254
|
Cd79a
|
CD79a molecule |
chr10_-_89454681 | 8.20 |
ENSRNOT00000028109
|
Brca1
|
BRCA1, DNA repair associated |
chr15_-_30019055 | 8.17 |
ENSRNOT00000073984
|
AABR07017681.1
|
|
chr9_-_110936631 | 8.16 |
ENSRNOT00000064431
|
Fbxl17
|
F-box and leucine-rich repeat protein 17 |
chr9_-_9675110 | 8.15 |
ENSRNOT00000073294
|
Vav1
|
vav guanine nucleotide exchange factor 1 |
chr10_-_103685844 | 8.15 |
ENSRNOT00000064284
|
Cd300lf
|
Cd300 molecule-like family member F |
chr9_+_65620658 | 8.14 |
ENSRNOT00000084498
|
Casp8
|
caspase 8 |
chr12_+_16912249 | 8.13 |
ENSRNOT00000085936
|
Tmem184a
|
transmembrane protein 184A |
chr13_-_80703615 | 8.12 |
ENSRNOT00000004599
|
Fmo4
|
flavin containing monooxygenase 4 |
chr12_+_19680712 | 8.12 |
ENSRNOT00000081310
|
AABR07035561.2
|
|
chr1_+_282640706 | 8.11 |
ENSRNOT00000073241
ENSRNOT00000080995 |
Ces2c
|
carboxylesterase 2C |
chr13_-_83457888 | 8.08 |
ENSRNOT00000076289
ENSRNOT00000004065 |
Sft2d2
|
SFT2 domain containing 2 |
chr15_+_108453147 | 8.07 |
ENSRNOT00000018486
|
Timm8a2
|
translocase of inner mitochondrial membrane 8A2 |
chr2_+_186776644 | 8.07 |
ENSRNOT00000046778
|
Fcrl3
|
Fc receptor-like 3 |
chr2_-_148722263 | 8.06 |
ENSRNOT00000017868
|
Serp1
|
stress-associated endoplasmic reticulum protein 1 |
chr6_+_2969333 | 8.01 |
ENSRNOT00000047356
|
Morn2
|
MORN repeat containing 2 |
chr20_-_9876008 | 7.99 |
ENSRNOT00000001537
|
Tff2
|
trefoil factor 2 |
chr1_-_101236065 | 7.98 |
ENSRNOT00000066834
|
Cd37
|
CD37 molecule |
chr3_+_20303979 | 7.97 |
ENSRNOT00000058331
|
AABR07051730.1
|
|
chr11_-_66759402 | 7.96 |
ENSRNOT00000003326
|
Hcls1
|
hematopoietic cell specific Lyn substrate 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.1 | 36.3 | GO:0046865 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
10.7 | 32.0 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
7.4 | 22.2 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
6.3 | 19.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
6.1 | 18.4 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
6.1 | 24.2 | GO:1902896 | terminal web assembly(GO:1902896) |
6.0 | 18.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
5.8 | 23.1 | GO:0031179 | peptide modification(GO:0031179) |
5.5 | 16.6 | GO:0031438 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
5.4 | 16.2 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
5.0 | 19.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
4.6 | 13.7 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
4.5 | 18.1 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
4.4 | 17.7 | GO:0071640 | regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
4.1 | 8.1 | GO:1902214 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) negative regulation of apoptotic cell clearance(GO:2000426) |
4.1 | 12.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
3.9 | 15.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
3.7 | 14.7 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
3.6 | 17.9 | GO:0015755 | carbohydrate utilization(GO:0009758) fructose transport(GO:0015755) |
3.5 | 10.5 | GO:1901726 | negative regulation of histone deacetylase activity(GO:1901726) |
3.5 | 10.4 | GO:0003192 | mitral valve formation(GO:0003192) transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
3.5 | 10.4 | GO:1901227 | negative regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901227) |
3.4 | 17.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
3.3 | 10.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
3.3 | 9.8 | GO:0061744 | motor behavior(GO:0061744) |
3.2 | 9.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
3.2 | 16.1 | GO:1904970 | brush border assembly(GO:1904970) |
3.2 | 9.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
3.1 | 6.2 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
3.1 | 6.2 | GO:0009751 | response to salicylic acid(GO:0009751) |
3.1 | 9.2 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) vitamin E metabolic process(GO:0042360) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
3.0 | 11.9 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
3.0 | 9.0 | GO:0006710 | androgen catabolic process(GO:0006710) |
2.9 | 8.8 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
2.9 | 14.6 | GO:0039019 | pronephric nephron development(GO:0039019) |
2.9 | 8.7 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
2.9 | 17.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
2.9 | 11.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.9 | 14.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
2.8 | 8.5 | GO:0043366 | beta selection(GO:0043366) |
2.8 | 17.0 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
2.8 | 11.1 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
2.8 | 5.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
2.7 | 8.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
2.7 | 10.7 | GO:0016240 | autophagosome docking(GO:0016240) |
2.7 | 8.0 | GO:1904383 | response to sodium phosphate(GO:1904383) |
2.7 | 8.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.6 | 10.6 | GO:0070839 | divalent metal ion export(GO:0070839) |
2.6 | 7.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.6 | 5.2 | GO:0015746 | citrate transport(GO:0015746) |
2.6 | 15.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.5 | 7.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
2.5 | 17.5 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
2.5 | 19.8 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
2.4 | 7.3 | GO:0002462 | tolerance induction to nonself antigen(GO:0002462) |
2.4 | 9.8 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
2.4 | 4.9 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
2.4 | 48.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
2.4 | 9.7 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
2.4 | 9.6 | GO:0002084 | protein depalmitoylation(GO:0002084) |
2.4 | 9.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
2.4 | 7.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.4 | 19.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
2.4 | 9.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.3 | 7.0 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
2.3 | 6.9 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
2.3 | 6.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
2.3 | 6.8 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
2.2 | 9.0 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
2.2 | 9.0 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
2.2 | 6.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
2.2 | 26.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
2.2 | 8.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
2.1 | 6.4 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
2.1 | 6.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
2.1 | 6.3 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
2.1 | 12.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
2.1 | 6.2 | GO:0034034 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) fatty-acyl-CoA catabolic process(GO:0036115) |
2.1 | 6.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
2.0 | 44.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
2.0 | 8.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.0 | 6.0 | GO:0051311 | spindle assembly involved in female meiosis(GO:0007056) meiotic metaphase plate congression(GO:0051311) |
2.0 | 6.0 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
2.0 | 10.0 | GO:0030070 | insulin processing(GO:0030070) |
2.0 | 6.0 | GO:0098759 | interleukin-1 biosynthetic process(GO:0042222) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) regulation of progesterone biosynthetic process(GO:2000182) |
2.0 | 5.9 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) N-acetylneuraminate biosynthetic process(GO:0046380) |
2.0 | 9.9 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
2.0 | 7.9 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
1.9 | 13.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
1.9 | 13.0 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
1.8 | 3.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.8 | 7.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.8 | 5.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.8 | 5.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.8 | 16.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
1.8 | 10.9 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
1.8 | 14.1 | GO:1903232 | melanosome assembly(GO:1903232) |
1.7 | 13.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.7 | 6.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.7 | 5.1 | GO:0060545 | regulation of nucleoside transport(GO:0032242) positive regulation of necroptotic process(GO:0060545) |
1.7 | 5.1 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
1.7 | 1.7 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
1.7 | 5.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.7 | 6.7 | GO:0030242 | pexophagy(GO:0030242) |
1.7 | 5.0 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
1.7 | 3.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
1.6 | 18.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.6 | 4.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.6 | 8.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.6 | 1.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.6 | 3.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
1.6 | 4.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.6 | 4.7 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
1.5 | 3.1 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
1.5 | 3.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
1.5 | 6.0 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.5 | 7.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.5 | 4.4 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.5 | 30.6 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.4 | 14.5 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
1.4 | 2.9 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.4 | 1.4 | GO:0002780 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
1.4 | 16.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
1.4 | 2.8 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.4 | 26.4 | GO:0006312 | mitotic recombination(GO:0006312) |
1.4 | 2.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.4 | 2.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
1.4 | 4.1 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
1.3 | 4.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.3 | 4.0 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
1.3 | 10.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.3 | 11.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.3 | 10.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.3 | 5.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.3 | 1.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.3 | 9.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.3 | 3.8 | GO:1904882 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
1.3 | 3.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.3 | 1.3 | GO:0021539 | subthalamus development(GO:0021539) |
1.3 | 10.2 | GO:0015871 | choline transport(GO:0015871) |
1.3 | 5.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.3 | 3.8 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
1.3 | 8.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
1.3 | 5.0 | GO:0010266 | response to vitamin B1(GO:0010266) |
1.2 | 24.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
1.2 | 3.6 | GO:0006431 | methionyl-tRNA aminoacylation(GO:0006431) |
1.2 | 10.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
1.2 | 7.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.2 | 7.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.2 | 4.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.2 | 7.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.2 | 4.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
1.2 | 5.8 | GO:0007144 | female meiosis I(GO:0007144) |
1.1 | 20.6 | GO:0001675 | acrosome assembly(GO:0001675) |
1.1 | 6.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.1 | 20.5 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
1.1 | 14.8 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
1.1 | 3.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
1.1 | 2.3 | GO:1901143 | insulin catabolic process(GO:1901143) |
1.1 | 3.4 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
1.1 | 4.5 | GO:0002418 | immune response to tumor cell(GO:0002418) |
1.1 | 5.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.1 | 3.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.1 | 7.8 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
1.1 | 8.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.1 | 20.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.1 | 3.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.1 | 3.3 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.1 | 12.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.1 | 4.4 | GO:0007296 | vitellogenesis(GO:0007296) |
1.1 | 6.5 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
1.1 | 3.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
1.0 | 4.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.0 | 10.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.0 | 4.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.0 | 11.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
1.0 | 29.8 | GO:0097502 | mannosylation(GO:0097502) |
1.0 | 12.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
1.0 | 8.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.0 | 8.2 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
1.0 | 9.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
1.0 | 4.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.0 | 6.9 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.0 | 8.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.0 | 6.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.0 | 2.9 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.0 | 3.9 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.0 | 2.9 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
1.0 | 2.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.0 | 4.8 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.0 | 6.7 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.9 | 1.9 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.9 | 3.8 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 8.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.9 | 10.2 | GO:0001878 | response to yeast(GO:0001878) |
0.9 | 9.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.9 | 12.9 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.9 | 5.4 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.9 | 18.9 | GO:0006298 | mismatch repair(GO:0006298) |
0.9 | 3.6 | GO:0070537 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) histone H2A K63-linked deubiquitination(GO:0070537) |
0.9 | 6.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.9 | 6.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.9 | 4.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.9 | 4.4 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.9 | 3.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.9 | 3.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.9 | 12.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.8 | 3.4 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.8 | 10.0 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.8 | 10.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.8 | 1.7 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.8 | 4.9 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.8 | 0.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.8 | 4.9 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.8 | 3.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.8 | 7.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.8 | 3.1 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.8 | 6.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.8 | 12.2 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.8 | 8.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.8 | 2.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.8 | 0.8 | GO:0071245 | cellular response to carbon monoxide(GO:0071245) |
0.7 | 6.7 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.7 | 3.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 8.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.7 | 5.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.7 | 9.5 | GO:0097068 | response to thyroxine(GO:0097068) |
0.7 | 2.9 | GO:0007135 | meiosis II(GO:0007135) |
0.7 | 23.8 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.7 | 28.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.7 | 2.2 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.7 | 17.3 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.7 | 5.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.7 | 10.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.7 | 5.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.7 | 2.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.7 | 2.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.7 | 2.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.7 | 4.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.7 | 0.7 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.7 | 4.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.7 | 1.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.7 | 31.1 | GO:1901998 | toxin transport(GO:1901998) |
0.7 | 6.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.7 | 2.8 | GO:0097681 | double-strand break repair via alternative nonhomologous end joining(GO:0097681) |
0.7 | 3.4 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.7 | 3.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.7 | 6.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.7 | 6.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.7 | 1.3 | GO:0006296 | base-excision repair, AP site formation(GO:0006285) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.7 | 2.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.7 | 3.3 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.7 | 2.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.7 | 6.5 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.6 | 6.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 4.3 | GO:0043482 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.6 | 6.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.6 | 2.5 | GO:0010045 | response to nickel cation(GO:0010045) |
0.6 | 4.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 9.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.6 | 6.1 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.6 | 1.8 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.6 | 15.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.6 | 1.8 | GO:2000619 | regulation of glucose mediated signaling pathway(GO:1902659) regulation of histone H4-K16 acetylation(GO:2000618) negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.6 | 3.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.6 | 5.4 | GO:0015866 | ADP transport(GO:0015866) |
0.6 | 6.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.6 | 17.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.6 | 6.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.6 | 6.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.6 | 1.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.6 | 19.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 7.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.6 | 5.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.6 | 5.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.6 | 1.7 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.6 | 8.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.6 | 4.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.6 | 4.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 6.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.6 | 4.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.6 | 3.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.6 | 3.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.6 | 4.5 | GO:0006983 | ER overload response(GO:0006983) |
0.6 | 1.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.6 | 0.6 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.6 | 2.2 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.5 | 3.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.5 | 1.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 7.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 | 11.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.5 | 7.9 | GO:0030220 | platelet formation(GO:0030220) |
0.5 | 4.7 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.5 | 7.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 1.6 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.5 | 1.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 2.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.5 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 1.5 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 7.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 4.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 3.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.5 | 6.5 | GO:0008334 | histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
0.5 | 0.5 | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.5 | 5.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.5 | 2.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.5 | 4.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 1.5 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.5 | 2.5 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.5 | 1.9 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.5 | 12.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.5 | 5.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 7.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 4.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.5 | 14.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 0.5 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.5 | 15.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.5 | 9.9 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.4 | 1.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 4.5 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 6.7 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.4 | 1.3 | GO:0021508 | floor plate formation(GO:0021508) |
0.4 | 2.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.4 | 1.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 11.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 7.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 3.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 3.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 2.1 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 27.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.4 | 0.8 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.4 | 1.2 | GO:1900095 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 4.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.4 | 3.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 6.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.4 | 2.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.4 | 15.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.4 | 2.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 5.9 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.4 | 15.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.4 | 5.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 0.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.4 | 8.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.4 | 1.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 5.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 2.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.4 | 3.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 2.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 2.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.4 | 19.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.4 | 5.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.4 | 3.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 2.8 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.3 | 2.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 1.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.3 | 3.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 7.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.3 | 3.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 1.0 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 1.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 1.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.3 | 3.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.3 | 7.0 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.3 | 5.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 5.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.0 | GO:0031989 | bombesin receptor signaling pathway(GO:0031989) |
0.3 | 2.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 6.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.0 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.3 | 2.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 3.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 1.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.3 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 1.6 | GO:0072014 | proximal tubule development(GO:0072014) |
0.3 | 3.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 2.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 2.8 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.3 | 3.8 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.3 | 3.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 1.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 3.3 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.3 | 3.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 5.8 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.3 | 3.0 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 1.8 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.3 | 0.9 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 4.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 2.6 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 8.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 15.1 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.3 | 11.9 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.3 | 0.9 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 0.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.3 | 5.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 5.5 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.3 | 2.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.9 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.3 | 1.9 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 3.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 8.1 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.3 | 2.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.3 | 5.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 1.3 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 7.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 1.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 2.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 2.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 0.5 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.3 | 2.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 2.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 3.7 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 3.0 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.2 | 1.5 | GO:0009446 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 1.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.5 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.2 | 22.6 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 0.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.2 | 1.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 11.0 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.2 | 2.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 0.9 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 10.1 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.2 | 4.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.2 | 3.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 2.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 4.4 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 1.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 6.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 1.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 11.3 | GO:0048645 | organ formation(GO:0048645) |
0.2 | 1.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 1.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 5.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 1.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.8 | GO:0061709 | reticulophagy(GO:0061709) |
0.2 | 1.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 3.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 1.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 6.2 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.2 | 6.6 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.2 | 1.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
0.2 | 2.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 5.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 2.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 2.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 0.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.2 | 0.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 1.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 3.9 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 6.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 1.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 2.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 2.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 2.3 | GO:0050716 | positive regulation of interleukin-1 beta production(GO:0032731) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.2 | 0.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 2.9 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.2 | 1.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.6 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 1.9 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 2.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 3.0 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 1.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 1.5 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 1.8 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 2.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 2.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 2.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 3.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 1.5 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 3.7 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 2.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 1.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.9 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.7 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 1.3 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.1 | 5.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 1.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 1.7 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 1.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 3.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 3.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 2.4 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 1.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 2.7 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.5 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 2.8 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 1.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.8 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.1 | 0.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 78.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 2.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.7 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.6 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.1 | 0.5 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.1 | 1.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.3 | GO:0021684 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar cortex formation(GO:0021697) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 2.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.8 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.5 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.8 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 7.4 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 1.1 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.0 | 0.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 1.7 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 2.1 | GO:0007369 | gastrulation(GO:0007369) |
0.0 | 0.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 2.0 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.0 | 0.4 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.6 | GO:0001708 | cell fate specification(GO:0001708) |
0.0 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.6 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.1 | GO:1903758 | regulation of postsynaptic density protein 95 clustering(GO:1902897) positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 4.8 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
4.6 | 18.4 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
4.5 | 13.4 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
4.4 | 13.2 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
4.2 | 25.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
3.9 | 15.5 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
3.6 | 10.7 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
3.3 | 10.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.6 | 20.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.4 | 17.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.3 | 11.6 | GO:0034455 | t-UTP complex(GO:0034455) |
2.3 | 43.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
2.2 | 2.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
2.2 | 17.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
2.2 | 2.2 | GO:1990037 | Lewy body core(GO:1990037) |
2.2 | 10.8 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
2.1 | 16.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.1 | 8.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.9 | 5.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.7 | 5.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
1.7 | 6.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
1.6 | 18.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.6 | 8.2 | GO:0035061 | interchromatin granule(GO:0035061) |
1.6 | 4.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.6 | 6.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.6 | 25.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.6 | 7.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.6 | 9.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.6 | 7.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.6 | 7.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.5 | 9.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
1.5 | 4.6 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.5 | 5.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.5 | 8.9 | GO:0031904 | endosome lumen(GO:0031904) |
1.5 | 5.9 | GO:0072487 | MSL complex(GO:0072487) |
1.5 | 14.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.4 | 18.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.4 | 8.5 | GO:1990357 | terminal web(GO:1990357) |
1.4 | 4.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.3 | 34.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.3 | 12.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.3 | 25.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.3 | 11.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.3 | 6.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
1.3 | 5.1 | GO:0097342 | ripoptosome(GO:0097342) |
1.3 | 10.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
1.3 | 6.3 | GO:0070552 | BRISC complex(GO:0070552) |
1.2 | 11.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.1 | 5.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
1.1 | 19.3 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
1.1 | 15.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.1 | 3.4 | GO:0035101 | FACT complex(GO:0035101) |
1.1 | 3.4 | GO:0055087 | Ski complex(GO:0055087) |
1.1 | 6.7 | GO:0070847 | core mediator complex(GO:0070847) |
1.1 | 14.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.1 | 7.6 | GO:0070449 | elongin complex(GO:0070449) |
1.1 | 10.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.0 | 8.3 | GO:0016589 | NURF complex(GO:0016589) |
1.0 | 7.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.0 | 10.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.0 | 3.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.0 | 5.8 | GO:0071547 | piP-body(GO:0071547) |
1.0 | 2.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.9 | 8.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.9 | 3.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.9 | 3.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.9 | 2.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.9 | 3.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.8 | 16.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.8 | 6.7 | GO:0043203 | axon hillock(GO:0043203) |
0.8 | 5.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.8 | 2.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.8 | 22.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.8 | 17.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.8 | 40.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.8 | 5.5 | GO:0001652 | granular component(GO:0001652) |
0.8 | 4.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.8 | 3.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.8 | 6.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.8 | 9.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 6.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.7 | 2.2 | GO:0000811 | GINS complex(GO:0000811) |
0.7 | 3.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.7 | 6.6 | GO:0097433 | dense body(GO:0097433) |
0.7 | 5.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.7 | 5.6 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 51.7 | GO:0045095 | keratin filament(GO:0045095) |
0.7 | 2.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.7 | 18.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.7 | 4.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.7 | 11.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 8.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.7 | 3.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 2.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.6 | 3.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.6 | 5.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.6 | 5.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 5.0 | GO:0034709 | methylosome(GO:0034709) |
0.6 | 7.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.6 | 8.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.6 | 3.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.6 | 10.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.6 | 3.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.6 | 4.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.6 | 1.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.6 | 2.8 | GO:0043293 | apoptosome(GO:0043293) |
0.5 | 9.8 | GO:0000800 | lateral element(GO:0000800) |
0.5 | 3.3 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 6.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 4.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 3.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.5 | 3.2 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 17.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 23.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 1.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 1.5 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.5 | 1.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 6.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 1.5 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
0.5 | 6.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.5 | 48.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.5 | 13.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 34.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.5 | 5.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 1.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 38.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 1.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 9.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.5 | 1.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 4.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 2.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 4.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 1.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 4.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 1.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 46.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 10.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 2.0 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.4 | 3.2 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 4.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 1.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 10.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 5.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 3.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 5.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 7.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 3.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 2.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 3.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 9.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 7.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 9.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 5.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 11.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 19.4 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 2.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 2.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 3.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 3.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.3 | 7.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 1.8 | GO:0048500 | signal recognition particle(GO:0048500) |
0.3 | 4.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 2.0 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 4.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 3.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 2.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 28.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 3.6 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.2 | 8.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 1.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 16.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 3.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 2.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 3.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 9.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 2.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 9.9 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 10.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 6.1 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.3 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.2 | 1.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.7 | GO:0002081 | inner acrosomal membrane(GO:0002079) outer acrosomal membrane(GO:0002081) |
0.2 | 3.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 3.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 1.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 2.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 12.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 3.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 2.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 7.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 4.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 11.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 3.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 2.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.9 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 2.7 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 71.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 8.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 18.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 2.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 6.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 19.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 2.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 19.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 6.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.7 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 1.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 2.2 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 4.5 | GO:0005814 | centriole(GO:0005814) |
0.1 | 4.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 2.5 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.0 | 8.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.0 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.7 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 5.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 25.8 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
5.5 | 38.5 | GO:0035375 | zymogen binding(GO:0035375) |
4.8 | 14.4 | GO:0008458 | carnitine O-octanoyltransferase activity(GO:0008458) O-octanoyltransferase activity(GO:0016414) |
4.2 | 16.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
4.1 | 36.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
3.9 | 15.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.8 | 23.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
3.6 | 3.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
3.6 | 10.9 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
3.5 | 10.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
3.4 | 10.1 | GO:0004040 | amidase activity(GO:0004040) |
3.3 | 9.8 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
3.2 | 9.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
3.1 | 12.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
3.1 | 9.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
3.1 | 9.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
3.0 | 9.0 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
3.0 | 8.9 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
2.9 | 8.8 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
2.9 | 14.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
2.9 | 8.7 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
2.7 | 16.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
2.7 | 13.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
2.6 | 5.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) |
2.6 | 10.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.6 | 15.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.4 | 12.0 | GO:0016936 | galactoside binding(GO:0016936) |
2.4 | 16.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
2.3 | 7.0 | GO:0017042 | glycosylceramidase activity(GO:0017042) |
2.3 | 7.0 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
2.3 | 7.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
2.2 | 20.1 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
2.2 | 17.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
2.2 | 6.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
2.1 | 6.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.0 | 8.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
2.0 | 10.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.0 | 58.7 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
2.0 | 6.0 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
2.0 | 17.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.0 | 3.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.9 | 13.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.9 | 5.8 | GO:0001565 | phorbol ester receptor activity(GO:0001565) |
1.9 | 22.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.9 | 7.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.9 | 7.6 | GO:0051870 | methotrexate binding(GO:0051870) |
1.9 | 15.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.9 | 5.6 | GO:0008384 | NF-kappaB-inducing kinase activity(GO:0004704) IkappaB kinase activity(GO:0008384) |
1.8 | 7.1 | GO:0045159 | myosin II binding(GO:0045159) |
1.8 | 5.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
1.8 | 10.6 | GO:0000150 | recombinase activity(GO:0000150) |
1.8 | 38.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.7 | 10.5 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
1.7 | 13.7 | GO:0045545 | syndecan binding(GO:0045545) |
1.7 | 5.1 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
1.7 | 6.8 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
1.7 | 23.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
1.7 | 5.1 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.7 | 8.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.7 | 6.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.7 | 5.0 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
1.5 | 6.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.5 | 4.6 | GO:0004335 | galactokinase activity(GO:0004335) |
1.5 | 6.0 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
1.5 | 4.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.5 | 4.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.5 | 4.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.5 | 5.8 | GO:0034584 | piRNA binding(GO:0034584) |
1.4 | 14.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.4 | 4.3 | GO:0004359 | glutaminase activity(GO:0004359) |
1.4 | 18.4 | GO:1990405 | protein antigen binding(GO:1990405) |
1.4 | 4.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.4 | 9.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.4 | 6.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.4 | 9.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.4 | 5.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
1.4 | 13.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.4 | 9.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.3 | 6.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.3 | 39.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.3 | 5.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
1.3 | 6.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.3 | 29.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.3 | 3.8 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
1.3 | 3.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.2 | 21.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.2 | 6.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.2 | 3.6 | GO:0004825 | methionine-tRNA ligase activity(GO:0004825) |
1.2 | 2.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.2 | 11.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.2 | 3.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
1.1 | 3.4 | GO:0042806 | fucose binding(GO:0042806) |
1.1 | 2.3 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
1.1 | 12.4 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
1.1 | 3.4 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.1 | 21.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
1.1 | 3.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
1.1 | 5.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.1 | 2.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.1 | 4.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.1 | 5.3 | GO:1990254 | keratin filament binding(GO:1990254) |
1.0 | 6.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.0 | 6.2 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.0 | 3.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.0 | 11.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.0 | 10.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.0 | 5.0 | GO:0070513 | death domain binding(GO:0070513) |
1.0 | 11.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.0 | 6.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.0 | 5.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.0 | 10.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.0 | 1.0 | GO:0008311 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
1.0 | 20.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
1.0 | 42.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.0 | 2.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.0 | 3.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.0 | 15.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.0 | 4.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.9 | 8.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.9 | 4.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.9 | 4.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.9 | 2.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.9 | 0.9 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.9 | 12.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.9 | 7.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.9 | 16.2 | GO:0005537 | mannose binding(GO:0005537) |
0.9 | 4.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.9 | 1.8 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.9 | 18.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.9 | 7.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.9 | 2.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.9 | 17.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.9 | 3.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.9 | 2.6 | GO:0052724 | inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.9 | 5.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.9 | 6.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.8 | 4.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.8 | 3.4 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.8 | 3.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 6.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.8 | 4.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.8 | 4.0 | GO:0032564 | dATP binding(GO:0032564) |
0.8 | 21.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.8 | 9.4 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.8 | 7.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.8 | 14.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.8 | 6.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.8 | 6.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.7 | 9.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.7 | 12.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.7 | 3.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.7 | 2.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.7 | 7.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 9.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.7 | 4.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.7 | 7.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.7 | 5.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 10.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.7 | 6.7 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.7 | 5.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.7 | 9.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.7 | 3.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 14.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 5.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 9.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.6 | 39.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.6 | 3.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.6 | 3.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.6 | 6.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.6 | 1.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.6 | 2.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 17.3 | GO:0016849 | cyclase activity(GO:0009975) phosphorus-oxygen lyase activity(GO:0016849) |
0.6 | 5.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.6 | 2.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.6 | 23.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.6 | 7.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 1.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.6 | 5.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.6 | 5.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.6 | 2.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 25.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.6 | 11.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.6 | 3.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 19.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.6 | 8.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.6 | 6.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 5.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.6 | 7.3 | GO:0008061 | chitin binding(GO:0008061) |
0.6 | 3.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.5 | 3.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 4.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.5 | 3.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.5 | 6.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.5 | 6.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.5 | 28.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.5 | 3.7 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.5 | 13.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 1.6 | GO:0000991 | transcription factor activity, core RNA polymerase II binding(GO:0000991) |
0.5 | 11.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 2.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 3.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 2.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.5 | 16.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.5 | 7.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.5 | 1.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 2.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.5 | 2.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 1.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.5 | 41.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.4 | 3.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 2.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 1.3 | GO:0000703 | oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity(GO:0000703) |
0.4 | 4.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 11.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 1.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 2.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 3.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.4 | 8.9 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 5.2 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.4 | 9.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 3.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 2.3 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 1.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.4 | 4.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 7.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 6.7 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 4.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.4 | 1.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 10.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.3 | 3.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 0.7 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.3 | 12.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 10.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 15.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 4.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 12.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.3 | 1.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 2.3 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 68.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 0.9 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.3 | 1.5 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
0.3 | 6.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 7.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 24.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.3 | 6.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.3 | 1.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.3 | 1.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 3.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.1 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.3 | 2.1 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 1.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 3.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 1.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 1.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 1.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 5.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 3.5 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 6.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 2.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 7.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 6.6 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.2 | 1.4 | GO:0050544 | Toll-like receptor 4 binding(GO:0035662) arachidonic acid binding(GO:0050544) |
0.2 | 1.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.5 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.2 | 7.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 3.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 1.6 | GO:0070697 | activin receptor binding(GO:0070697) |
0.2 | 0.7 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.2 | 2.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.5 | GO:0050664 | NAD(P)H oxidase activity(GO:0016174) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 1.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 3.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 4.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 2.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 2.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 1.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 5.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 53.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 1.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.4 | GO:0032427 | GBD domain binding(GO:0032427) |
0.2 | 1.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 3.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 6.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.6 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.2 | 2.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 2.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 3.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.5 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 6.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 2.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 1.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 26.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 1.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 2.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 20.2 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 3.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 1.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 2.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 2.4 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 1.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 5.9 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 2.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.8 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 3.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 14.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 2.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 2.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 1.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 2.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 2.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 1.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 2.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 2.0 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) snRNA stem-loop binding(GO:0035614) |
0.1 | 5.6 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.1 | 4.7 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 5.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 2.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.6 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 2.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 1.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 8.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 79.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 5.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.0 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 1.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 1.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 3.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 1.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 2.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 1.0 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.6 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 1.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 1.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 1.2 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 38.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.2 | 60.0 | PID EPO PATHWAY | EPO signaling pathway |
1.1 | 19.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.1 | 40.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.9 | 27.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 46.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.8 | 28.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.8 | 10.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 26.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 24.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 6.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 11.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 13.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.6 | 28.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.6 | 4.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.6 | 23.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.6 | 20.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 10.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 28.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 19.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 12.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 4.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.5 | 5.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 17.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 13.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 5.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.4 | 36.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 1.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 4.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 5.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 2.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 15.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 3.3 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 1.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 17.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 6.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 9.4 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 2.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 4.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 7.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 2.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 52.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 2.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 2.1 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 1.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 3.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 3.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 9.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 2.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 6.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 2.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 2.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 5.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 8.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 3.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 16.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.5 | 8.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.4 | 43.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.2 | 24.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.0 | 21.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
2.0 | 21.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.9 | 22.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.6 | 35.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.6 | 23.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.5 | 26.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
1.5 | 7.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
1.5 | 24.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.5 | 2.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.4 | 30.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.3 | 11.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.2 | 16.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.2 | 22.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.1 | 20.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
1.1 | 38.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.1 | 2.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.0 | 10.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.0 | 12.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.0 | 8.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.0 | 18.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.9 | 10.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.9 | 35.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.9 | 15.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.9 | 10.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.8 | 7.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.8 | 10.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.8 | 84.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.8 | 13.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.8 | 7.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 22.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.8 | 23.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.8 | 30.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.7 | 16.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.7 | 19.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.7 | 13.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.7 | 18.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.7 | 9.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.7 | 8.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.7 | 13.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.7 | 2.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.6 | 14.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.6 | 25.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.6 | 11.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.6 | 20.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 12.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.6 | 13.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 10.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.6 | 6.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 16.1 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.5 | 1.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.5 | 5.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 6.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 7.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 1.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 9.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 7.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 12.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 2.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 2.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 2.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.4 | 11.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.4 | 15.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 6.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 9.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 2.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 10.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 3.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.3 | 13.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 2.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 6.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 4.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 6.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 24.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 7.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 4.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 6.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 1.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.3 | 1.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 15.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 7.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 2.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 3.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 7.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 4.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 6.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 1.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 1.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 2.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 2.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 3.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 2.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 3.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 8.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 2.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.2 | 13.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 2.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 3.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 5.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 4.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 4.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 4.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 5.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 1.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.6 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 3.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |